| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T224 |
0-12 |
NN |
denotes |
Introduction |
| T225 |
13-26 |
NNS |
denotes |
Coronaviruses |
| T226 |
27-28 |
-LRB- |
denotes |
( |
| T227 |
28-32 |
NNS |
denotes |
CoVs |
| T228 |
32-33 |
-RRB- |
denotes |
) |
| T229 |
34-37 |
VBP |
denotes |
are |
| T230 |
38-47 |
VBN |
denotes |
enveloped |
| T231 |
48-57 |
NNS |
denotes |
pathogens |
| T232 |
58-69 |
JJ |
denotes |
responsible |
| T233 |
70-73 |
IN |
denotes |
for |
| T234 |
74-82 |
JJ |
denotes |
multiple |
| T235 |
83-94 |
JJ |
denotes |
respiratory |
| T236 |
95-104 |
NNS |
denotes |
disorders |
| T237 |
105-107 |
IN |
denotes |
of |
| T238 |
108-115 |
VBG |
denotes |
varying |
| T239 |
116-124 |
NN |
denotes |
severity |
| T240 |
125-127 |
IN |
denotes |
in |
| T241 |
128-135 |
NN |
denotes |
humans1 |
| T242 |
137-144 |
JJ |
denotes |
Certain |
| T243 |
145-149 |
NNS |
denotes |
CoVs |
| T244 |
150-159 |
VBP |
denotes |
represent |
| T245 |
160-161 |
DT |
denotes |
a |
| T246 |
162-173 |
JJ |
denotes |
significant |
| T247 |
174-180 |
NN |
denotes |
threat |
| T248 |
181-183 |
TO |
denotes |
to |
| T249 |
184-190 |
JJ |
denotes |
global |
| T250 |
191-196 |
JJ |
denotes |
human |
| T251 |
197-203 |
NN |
denotes |
health |
| T252 |
203-204 |
-COMMA- |
denotes |
, |
| T253 |
205-207 |
IN |
denotes |
as |
| T254 |
208-219 |
VBN |
denotes |
illustrated |
| T255 |
220-222 |
IN |
denotes |
by |
| T256 |
223-232 |
NNS |
denotes |
outbreaks |
| T257 |
233-235 |
IN |
denotes |
of |
| T258 |
236-242 |
JJ |
denotes |
severe |
| T259 |
243-248 |
JJ |
denotes |
acute |
| T260 |
249-260 |
JJ |
denotes |
respiratory |
| T261 |
261-269 |
NN |
denotes |
syndrome |
| T262 |
270-281 |
NN |
denotes |
coronavirus |
| T263 |
282-283 |
-LRB- |
denotes |
( |
| T264 |
283-291 |
NN |
denotes |
SARS-CoV |
| T265 |
291-292 |
-RRB- |
denotes |
) |
| T266 |
293-295 |
IN |
denotes |
in |
| T267 |
296-301 |
CD |
denotes |
20032 |
| T268 |
301-302 |
-COMMA- |
denotes |
, |
| T269 |
303-309 |
NNP |
denotes |
Middle |
| T270 |
310-314 |
NNP |
denotes |
East |
| T271 |
315-326 |
JJ |
denotes |
respiratory |
| T272 |
327-335 |
NN |
denotes |
syndrome |
| T273 |
336-347 |
NN |
denotes |
coronavirus |
| T274 |
348-349 |
-LRB- |
denotes |
( |
| T275 |
349-357 |
NN |
denotes |
MERS-CoV |
| T276 |
357-358 |
-RRB- |
denotes |
) |
| T277 |
359-361 |
IN |
denotes |
in |
| T278 |
362-367 |
CD |
denotes |
20123 |
| T279 |
367-368 |
-COMMA- |
denotes |
, |
| T280 |
369-372 |
CC |
denotes |
and |
| T281 |
373-377 |
RBS |
denotes |
most |
| T282 |
378-386 |
RB |
denotes |
recently |
| T283 |
387-389 |
IN |
denotes |
of |
| T284 |
390-401 |
NN |
denotes |
SARS-CoV-24 |
| T285 |
403-408 |
VBN |
denotes |
Given |
| T286 |
409-414 |
PRP-DOLLAR- |
denotes |
their |
| T287 |
415-424 |
NN |
denotes |
mortality |
| T288 |
425-430 |
NNS |
denotes |
rates |
| T289 |
430-431 |
-COMMA- |
denotes |
, |
| T290 |
432-435 |
DT |
denotes |
the |
| T291 |
436-443 |
JJ |
denotes |
current |
| T292 |
444-448 |
NN |
denotes |
lack |
| T293 |
449-451 |
IN |
denotes |
of |
| T294 |
452-460 |
VBN |
denotes |
targeted |
| T295 |
461-471 |
NNS |
denotes |
treatments |
| T296 |
472-475 |
CC |
denotes |
and |
| T297 |
476-484 |
JJ |
denotes |
licensed |
| T298 |
485-493 |
NNS |
denotes |
vaccines |
| T299 |
493-494 |
-COMMA- |
denotes |
, |
| T300 |
495-498 |
CC |
denotes |
and |
| T301 |
499-504 |
PRP-DOLLAR- |
denotes |
their |
| T302 |
505-513 |
NN |
denotes |
capacity |
| T303 |
514-516 |
TO |
denotes |
to |
| T304 |
517-525 |
VB |
denotes |
transmit |
| T305 |
526-533 |
IN |
denotes |
between |
| T306 |
534-540 |
NNS |
denotes |
humans |
| T307 |
541-544 |
CC |
denotes |
and |
| T308 |
545-551 |
IN |
denotes |
across |
| T309 |
552-559 |
NNS |
denotes |
species |
| T310 |
560-571 |
NN |
denotes |
barriers5,6 |
| T311 |
571-572 |
-COMMA- |
denotes |
, |
| T312 |
573-578 |
EX |
denotes |
there |
| T313 |
579-581 |
VBZ |
denotes |
is |
| T314 |
582-584 |
DT |
denotes |
an |
| T315 |
585-591 |
JJ |
denotes |
urgent |
| T316 |
592-596 |
NN |
denotes |
need |
| T317 |
597-600 |
IN |
denotes |
for |
| T318 |
601-610 |
JJ |
denotes |
effective |
| T319 |
611-626 |
NNS |
denotes |
countermeasures |
| T320 |
627-629 |
TO |
denotes |
to |
| T321 |
630-636 |
VB |
denotes |
combat |
| T322 |
637-642 |
DT |
denotes |
these |
| T323 |
643-652 |
NNS |
denotes |
pathogens |
| T324 |
654-661 |
VBG |
denotes |
Ongoing |
| T325 |
662-669 |
NN |
denotes |
vaccine |
| T326 |
670-681 |
NN |
denotes |
development |
| T327 |
682-689 |
NNS |
denotes |
efforts |
| T328 |
690-695 |
NN |
denotes |
focus |
| T329 |
696-698 |
IN |
denotes |
on |
| T330 |
699-702 |
DT |
denotes |
the |
| T331 |
703-708 |
NN |
denotes |
spike |
| T332 |
709-710 |
-LRB- |
denotes |
( |
| T333 |
710-711 |
NN |
denotes |
S |
| T334 |
711-712 |
-RRB- |
denotes |
) |
| T335 |
713-721 |
NNS |
denotes |
proteins |
| T336 |
722-726 |
WDT |
denotes |
that |
| T337 |
727-735 |
VBP |
denotes |
protrude |
| T338 |
736-740 |
IN |
denotes |
from |
| T339 |
741-744 |
DT |
denotes |
the |
| T340 |
745-750 |
JJ |
denotes |
viral |
| T341 |
751-759 |
NN |
denotes |
envelope |
| T342 |
760-763 |
CC |
denotes |
and |
| T343 |
764-774 |
VB |
denotes |
constitute |
| T344 |
775-778 |
DT |
denotes |
the |
| T345 |
779-783 |
JJ |
denotes |
main |
| T346 |
784-790 |
NN |
denotes |
target |
| T347 |
791-793 |
IN |
denotes |
of |
| T348 |
794-806 |
VBG |
denotes |
neutralizing |
| T349 |
807-820 |
NN |
denotes |
antibodies7,8 |
| T350 |
822-827 |
DT |
denotes |
These |
| T351 |
828-836 |
JJ |
denotes |
trimeric |
| T352 |
837-838 |
NN |
denotes |
S |
| T353 |
839-847 |
NNS |
denotes |
proteins |
| T354 |
848-855 |
VBP |
denotes |
mediate |
| T355 |
856-865 |
JJ |
denotes |
host-cell |
| T356 |
866-871 |
NN |
denotes |
entry |
| T357 |
872-876 |
IN |
denotes |
with |
| T358 |
877-880 |
DT |
denotes |
the |
| T359 |
881-883 |
NN |
denotes |
S1 |
| T360 |
884-887 |
CC |
denotes |
and |
| T361 |
888-890 |
NN |
denotes |
S2 |
| T362 |
891-899 |
NNS |
denotes |
subunits |
| T363 |
900-911 |
JJ |
denotes |
responsible |
| T364 |
912-915 |
IN |
denotes |
for |
| T365 |
916-923 |
VBG |
denotes |
binding |
| T366 |
924-926 |
TO |
denotes |
to |
| T367 |
927-930 |
DT |
denotes |
the |
| T368 |
931-940 |
NN |
denotes |
host-cell |
| T369 |
941-949 |
NN |
denotes |
receptor |
| T370 |
950-953 |
CC |
denotes |
and |
| T371 |
954-966 |
VBG |
denotes |
facilitating |
| T372 |
967-975 |
NN |
denotes |
membrane |
| T373 |
976-982 |
NN |
denotes |
fusion |
| T374 |
982-983 |
-COMMA- |
denotes |
, |
| T375 |
984-1000 |
NN |
denotes |
respectively9–11 |
| T376 |
1002-1006 |
NNS |
denotes |
MERS |
| T377 |
1007-1008 |
NN |
denotes |
S |
| T378 |
1009-1014 |
VBZ |
denotes |
binds |
| T379 |
1015-1017 |
TO |
denotes |
to |
| T380 |
1018-1038 |
NN |
denotes |
dipeptidyl-peptidase |
| T381 |
1039-1040 |
CD |
denotes |
4 |
| T382 |
1041-1042 |
-LRB- |
denotes |
( |
| T383 |
1042-1046 |
NN |
denotes |
DPP4 |
| T384 |
1046-1047 |
-RRB- |
denotes |
) |
| T385 |
1047-1049 |
CD |
denotes |
12 |
| T386 |
1049-1050 |
-COMMA- |
denotes |
, |
| T387 |
1051-1058 |
IN |
denotes |
whereas |
| T388 |
1059-1063 |
NN |
denotes |
SARS |
| T389 |
1064-1067 |
NN |
denotes |
S13 |
| T390 |
1068-1071 |
CC |
denotes |
and |
| T391 |
1072-1087 |
NN |
denotes |
SARS-CoV-214,15 |
| T392 |
1088-1095 |
VBP |
denotes |
utilize |
| T393 |
1096-1118 |
JJ |
denotes |
angiotensin-converting |
| T394 |
1119-1125 |
NN |
denotes |
enzyme |
| T395 |
1126-1127 |
CD |
denotes |
2 |
| T396 |
1128-1129 |
-LRB- |
denotes |
( |
| T397 |
1129-1133 |
NN |
denotes |
ACE2 |
| T398 |
1133-1134 |
-RRB- |
denotes |
) |
| T399 |
1135-1137 |
IN |
denotes |
as |
| T400 |
1138-1139 |
DT |
denotes |
a |
| T401 |
1140-1144 |
NN |
denotes |
host |
| T402 |
1145-1153 |
JJ |
denotes |
cellular |
| T403 |
1154-1162 |
NN |
denotes |
receptor |
| T404 |
1164-1167 |
NN |
denotes |
CoV |
| T405 |
1168-1169 |
NN |
denotes |
S |
| T406 |
1170-1178 |
NNS |
denotes |
proteins |
| T407 |
1179-1182 |
VBP |
denotes |
are |
| T408 |
1183-1186 |
DT |
denotes |
the |
| T409 |
1187-1194 |
JJS |
denotes |
largest |
| T410 |
1195-1200 |
NN |
denotes |
class |
| T411 |
1201-1202 |
CD |
denotes |
I |
| T412 |
1203-1208 |
JJ |
denotes |
viral |
| T413 |
1209-1215 |
NN |
denotes |
fusion |
| T414 |
1216-1224 |
NNS |
denotes |
proteins |
| T415 |
1225-1231 |
NN |
denotes |
known9 |
| T416 |
1231-1232 |
-COMMA- |
denotes |
, |
| T417 |
1233-1236 |
CC |
denotes |
and |
| T418 |
1237-1240 |
VBP |
denotes |
are |
| T419 |
1241-1252 |
RB |
denotes |
extensively |
| T420 |
1253-1265 |
VBN |
denotes |
glycosylated |
| T421 |
1265-1266 |
-COMMA- |
denotes |
, |
| T422 |
1267-1271 |
IN |
denotes |
with |
| T423 |
1272-1276 |
NNP |
denotes |
SARS |
| T424 |
1277-1280 |
CC |
denotes |
and |
| T425 |
1281-1285 |
NNP |
denotes |
MERS |
| T426 |
1286-1287 |
NN |
denotes |
S |
| T427 |
1288-1301 |
NNS |
denotes |
glycoproteins |
| T428 |
1302-1306 |
CC |
denotes |
both |
| T429 |
1307-1315 |
VBG |
denotes |
encoding |
| T430 |
1316-1318 |
CD |
denotes |
69 |
| T431 |
1319-1327 |
JJ |
denotes |
N-linked |
| T432 |
1328-1334 |
NN |
denotes |
glycan |
| T433 |
1335-1342 |
NNS |
denotes |
sequons |
| T434 |
1343-1346 |
IN |
denotes |
per |
| T435 |
1347-1355 |
JJ |
denotes |
trimeric |
| T436 |
1356-1361 |
NN |
denotes |
spike |
| T437 |
1362-1366 |
IN |
denotes |
with |
| T438 |
1367-1377 |
NN |
denotes |
SARS-CoV-2 |
| T439 |
1378-1388 |
VBG |
denotes |
containing |
| T440 |
1389-1391 |
CD |
denotes |
66 |
| T441 |
1392-1397 |
NNS |
denotes |
sites |
| T442 |
1399-1404 |
DT |
denotes |
These |
| T443 |
1405-1418 |
NNS |
denotes |
modifications |
| T444 |
1419-1424 |
RB |
denotes |
often |
| T445 |
1425-1429 |
VBP |
denotes |
mask |
| T446 |
1430-1441 |
JJ |
denotes |
immunogenic |
| T447 |
1442-1449 |
NN |
denotes |
protein |
| T448 |
1450-1458 |
NNS |
denotes |
epitopes |
| T449 |
1459-1463 |
IN |
denotes |
from |
| T450 |
1464-1467 |
DT |
denotes |
the |
| T451 |
1468-1472 |
NN |
denotes |
host |
| T452 |
1473-1480 |
JJ |
denotes |
humoral |
| T453 |
1481-1487 |
JJ |
denotes |
immune |
| T454 |
1488-1494 |
NN |
denotes |
system |
| T455 |
1495-1497 |
IN |
denotes |
by |
| T456 |
1498-1507 |
VBG |
denotes |
occluding |
| T457 |
1508-1512 |
PRP |
denotes |
them |
| T458 |
1513-1517 |
IN |
denotes |
with |
| T459 |
1518-1530 |
JJ |
denotes |
host-derived |
| T460 |
1531-1543 |
NN |
denotes |
glycans16–18 |
| T461 |
1545-1549 |
DT |
denotes |
This |
| T462 |
1550-1560 |
NN |
denotes |
phenomenon |
| T463 |
1561-1563 |
IN |
denotes |
of |
| T464 |
1564-1570 |
JJ |
denotes |
immune |
| T465 |
1571-1578 |
NN |
denotes |
evasion |
| T466 |
1579-1581 |
IN |
denotes |
by |
| T467 |
1582-1591 |
JJ |
denotes |
molecular |
| T468 |
1592-1599 |
NN |
denotes |
mimicry |
| T469 |
1600-1603 |
CC |
denotes |
and |
| T470 |
1604-1610 |
NN |
denotes |
glycan |
| T471 |
1611-1620 |
NN |
denotes |
shielding |
| T472 |
1621-1624 |
VBZ |
denotes |
has |
| T473 |
1625-1629 |
VBN |
denotes |
been |
| T474 |
1630-1634 |
RB |
denotes |
well |
| T475 |
1635-1648 |
VBN |
denotes |
characterised |
| T476 |
1649-1655 |
IN |
denotes |
across |
| T477 |
1656-1661 |
JJ |
denotes |
other |
| T478 |
1662-1667 |
JJ |
denotes |
viral |
| T479 |
1668-1681 |
NNS |
denotes |
glycoproteins |
| T480 |
1681-1682 |
-COMMA- |
denotes |
, |
| T481 |
1683-1687 |
JJ |
denotes |
such |
| T482 |
1688-1690 |
IN |
denotes |
as |
| T483 |
1691-1696 |
NN |
denotes |
HIV-1 |
| T484 |
1697-1705 |
NN |
denotes |
envelope |
| T485 |
1706-1713 |
NN |
denotes |
protein |
| T486 |
1714-1715 |
-LRB- |
denotes |
( |
| T487 |
1715-1718 |
NN |
denotes |
Env |
| T488 |
1718-1719 |
-RRB- |
denotes |
) |
| T489 |
1719-1724 |
CD |
denotes |
19–21 |
| T490 |
1724-1725 |
-COMMA- |
denotes |
, |
| T491 |
1726-1735 |
NN |
denotes |
influenza |
| T492 |
1736-1749 |
NN |
denotes |
hemagglutinin |
| T493 |
1750-1751 |
-LRB- |
denotes |
( |
| T494 |
1751-1753 |
NN |
denotes |
HA |
| T495 |
1753-1754 |
-RRB- |
denotes |
) |
| T496 |
1754-1759 |
CD |
denotes |
22,23 |
| T497 |
1760-1763 |
CC |
denotes |
and |
| T498 |
1764-1769 |
NNP |
denotes |
Lassa |
| T499 |
1770-1775 |
NN |
denotes |
virus |
| T500 |
1776-1788 |
NN |
denotes |
glycoprotein |
| T501 |
1789-1796 |
NN |
denotes |
complex |
| T502 |
1797-1798 |
-LRB- |
denotes |
( |
| T503 |
1798-1802 |
NN |
denotes |
LASV |
| T504 |
1803-1806 |
NN |
denotes |
GPC |
| T505 |
1806-1807 |
-RRB- |
denotes |
) |
| T506 |
1807-1812 |
CD |
denotes |
24–26 |
| T507 |
1814-1822 |
JJ |
denotes |
Previous |
| T508 |
1823-1831 |
NNS |
denotes |
analyses |
| T509 |
1832-1834 |
IN |
denotes |
of |
| T510 |
1835-1840 |
JJ |
denotes |
viral |
| T511 |
1841-1847 |
NN |
denotes |
glycan |
| T512 |
1848-1855 |
NNS |
denotes |
shields |
| T513 |
1856-1860 |
VBP |
denotes |
have |
| T514 |
1861-1869 |
VBN |
denotes |
revealed |
| T515 |
1870-1873 |
DT |
denotes |
the |
| T516 |
1874-1882 |
NN |
denotes |
presence |
| T517 |
1883-1885 |
IN |
denotes |
of |
| T518 |
1886-1900 |
JJ |
denotes |
underprocessed |
| T519 |
1901-1918 |
JJ |
denotes |
oligomannose-type |
| T520 |
1919-1926 |
NNS |
denotes |
glycans |
| T521 |
1927-1931 |
WDT |
denotes |
that |
| T522 |
1932-1941 |
RB |
denotes |
seemingly |
| T523 |
1942-1947 |
VBP |
denotes |
arise |
| T524 |
1948-1951 |
JJ |
denotes |
due |
| T525 |
1952-1954 |
TO |
denotes |
to |
| T526 |
1955-1961 |
JJ |
denotes |
steric |
| T527 |
1962-1973 |
NNS |
denotes |
constraints |
| T528 |
1974-1978 |
WDT |
denotes |
that |
| T529 |
1979-1986 |
VBP |
denotes |
prevent |
| T530 |
1987-1993 |
NN |
denotes |
access |
| T531 |
1994-1996 |
IN |
denotes |
of |
| T532 |
1997-2003 |
NN |
denotes |
glycan |
| T533 |
2004-2014 |
NN |
denotes |
processing |
| T534 |
2015-2022 |
NNS |
denotes |
enzymes |
| T535 |
2023-2025 |
TO |
denotes |
to |
| T536 |
2026-2035 |
NN |
denotes |
substrate |
| T537 |
2036-2051 |
NN |
denotes |
glycans24,27,28 |
| T538 |
2051-2052 |
-COMMA- |
denotes |
, |
| T539 |
2053-2063 |
RB |
denotes |
especially |
| T540 |
2064-2068 |
WRB |
denotes |
when |
| T541 |
2069-2072 |
DT |
denotes |
the |
| T542 |
2073-2078 |
JJ |
denotes |
viral |
| T543 |
2079-2091 |
NN |
denotes |
glycoprotein |
| T544 |
2092-2095 |
VBZ |
denotes |
has |
| T545 |
2096-2103 |
VBN |
denotes |
evolved |
| T546 |
2104-2106 |
TO |
denotes |
to |
| T547 |
2107-2111 |
VB |
denotes |
mask |
| T548 |
2112-2123 |
JJ |
denotes |
immunogenic |
| T549 |
2124-2132 |
NNS |
denotes |
epitopes |
| T550 |
2133-2137 |
IN |
denotes |
with |
| T551 |
2138-2139 |
DT |
denotes |
a |
| T552 |
2140-2152 |
RB |
denotes |
particularly |
| T553 |
2153-2158 |
JJ |
denotes |
dense |
| T554 |
2159-2164 |
NN |
denotes |
array |
| T555 |
2165-2167 |
IN |
denotes |
of |
| T556 |
2168-2180 |
JJ |
denotes |
host-derived |
| T557 |
2181-2196 |
NN |
denotes |
glycans26,29–34 |
| T558 |
2198-2208 |
JJ |
denotes |
Restricted |
| T559 |
2209-2215 |
NN |
denotes |
access |
| T560 |
2216-2218 |
TO |
denotes |
to |
| T561 |
2219-2224 |
DT |
denotes |
these |
| T562 |
2225-2231 |
NN |
denotes |
glycan |
| T563 |
2232-2237 |
NNS |
denotes |
sites |
| T564 |
2238-2240 |
CC |
denotes |
or |
| T565 |
2241-2253 |
NN |
denotes |
interference |
| T566 |
2254-2258 |
IN |
denotes |
with |
| T567 |
2259-2270 |
VBG |
denotes |
surrounding |
| T568 |
2271-2278 |
NN |
denotes |
protein |
| T569 |
2279-2286 |
NN |
denotes |
surface |
| T570 |
2287-2289 |
CC |
denotes |
or |
| T571 |
2290-2302 |
VBG |
denotes |
neighbouring |
| T572 |
2303-2309 |
NN |
denotes |
glycan |
| T573 |
2310-2318 |
NNS |
denotes |
residues |
| T574 |
2319-2322 |
MD |
denotes |
can |
| T575 |
2323-2329 |
VB |
denotes |
render |
| T576 |
2330-2336 |
NN |
denotes |
glycan |
| T577 |
2337-2347 |
NN |
denotes |
processing |
| T578 |
2348-2355 |
NNS |
denotes |
enzymes |
| T579 |
2356-2367 |
JJ |
denotes |
ineffective |
| T580 |
2368-2370 |
IN |
denotes |
in |
| T581 |
2371-2379 |
JJ |
denotes |
specific |
| T582 |
2380-2395 |
NN |
denotes |
regions27,28,35 |
| T583 |
2397-2403 |
NN |
denotes |
Glycan |
| T584 |
2404-2414 |
NN |
denotes |
processing |
| T585 |
2415-2417 |
IN |
denotes |
on |
| T586 |
2418-2425 |
JJ |
denotes |
soluble |
| T587 |
2426-2439 |
NNS |
denotes |
glycoproteins |
| T588 |
2440-2443 |
VBZ |
denotes |
has |
| T589 |
2444-2448 |
RB |
denotes |
also |
| T590 |
2449-2453 |
VBN |
denotes |
been |
| T591 |
2454-2459 |
VBN |
denotes |
shown |
| T592 |
2460-2462 |
TO |
denotes |
to |
| T593 |
2463-2465 |
VB |
denotes |
be |
| T594 |
2466-2467 |
DT |
denotes |
a |
| T595 |
2468-2474 |
JJ |
denotes |
strong |
| T596 |
2475-2483 |
NN |
denotes |
reporter |
| T597 |
2484-2486 |
IN |
denotes |
of |
| T598 |
2487-2498 |
JJ |
denotes |
native-like |
| T599 |
2499-2506 |
NN |
denotes |
protein |
| T600 |
2507-2519 |
NN |
denotes |
architecture |
| T601 |
2520-2523 |
CC |
denotes |
and |
| T602 |
2524-2528 |
RB |
denotes |
thus |
| T603 |
2529-2538 |
NN |
denotes |
immunogen |
| T604 |
2539-2553 |
NN |
denotes |
integrity36–38 |
| T605 |
2553-2554 |
-SEMICOLON- |
denotes |
; |
| T606 |
2555-2558 |
CC |
denotes |
and |
| T607 |
2559-2565 |
NN |
denotes |
glycan |
| T608 |
2566-2576 |
NN |
denotes |
processing |
| T609 |
2577-2579 |
IN |
denotes |
on |
| T610 |
2580-2581 |
DT |
denotes |
a |
| T611 |
2582-2592 |
JJ |
denotes |
successful |
| T612 |
2593-2602 |
NN |
denotes |
immunogen |
| T613 |
2603-2612 |
NN |
denotes |
candidate |
| T614 |
2613-2619 |
MD |
denotes |
should |
| T615 |
2620-2629 |
RB |
denotes |
therefore |
| T616 |
2630-2635 |
VB |
denotes |
mimic |
| T617 |
2635-2636 |
-COMMA- |
denotes |
, |
| T618 |
2637-2639 |
RB |
denotes |
as |
| T619 |
2640-2647 |
RB |
denotes |
closely |
| T620 |
2648-2650 |
IN |
denotes |
as |
| T621 |
2651-2659 |
JJ |
denotes |
possible |
| T622 |
2659-2660 |
-COMMA- |
denotes |
, |
| T623 |
2661-2664 |
DT |
denotes |
the |
| T624 |
2665-2675 |
JJ |
denotes |
structural |
| T625 |
2676-2684 |
NNS |
denotes |
features |
| T626 |
2685-2693 |
VBN |
denotes |
observed |
| T627 |
2694-2696 |
IN |
denotes |
on |
| T628 |
2697-2700 |
DT |
denotes |
the |
| T629 |
2701-2707 |
JJ |
denotes |
native |
| T630 |
2708-2718 |
NN |
denotes |
virus39,40 |
| T631 |
2720-2724 |
RB |
denotes |
Here |
| T632 |
2724-2725 |
-COMMA- |
denotes |
, |
| T633 |
2726-2728 |
PRP |
denotes |
we |
| T634 |
2729-2736 |
VBP |
denotes |
provide |
| T635 |
2737-2743 |
JJ |
denotes |
global |
| T636 |
2744-2747 |
CC |
denotes |
and |
| T637 |
2748-2761 |
JJ |
denotes |
site-specific |
| T638 |
2762-2770 |
NNS |
denotes |
analyses |
| T639 |
2771-2773 |
IN |
denotes |
of |
| T640 |
2774-2782 |
JJ |
denotes |
N-linked |
| T641 |
2783-2796 |
NN |
denotes |
glycosylation |
| T642 |
2797-2799 |
IN |
denotes |
on |
| T643 |
2800-2807 |
JJ |
denotes |
soluble |
| T644 |
2808-2812 |
NNS |
denotes |
SARS |
| T645 |
2812-2813 |
-COMMA- |
denotes |
, |
| T646 |
2814-2818 |
NNS |
denotes |
MERS |
| T647 |
2819-2822 |
CC |
denotes |
and |
| T648 |
2823-2827 |
NN |
denotes |
HKU1 |
| T649 |
2828-2831 |
NN |
denotes |
CoV |
| T650 |
2832-2833 |
NN |
denotes |
S |
| T651 |
2834-2847 |
NNS |
denotes |
glycoproteins |
| T652 |
2848-2851 |
CC |
denotes |
and |
| T653 |
2852-2858 |
VB |
denotes |
reveal |
| T654 |
2859-2868 |
JJ |
denotes |
extensive |
| T655 |
2869-2882 |
NN |
denotes |
heterogeneity |
| T656 |
2882-2883 |
-COMMA- |
denotes |
, |
| T657 |
2884-2891 |
VBG |
denotes |
ranging |
| T658 |
2892-2896 |
IN |
denotes |
from |
| T659 |
2897-2914 |
JJ |
denotes |
oligomannose-type |
| T660 |
2915-2922 |
NNS |
denotes |
glycans |
| T661 |
2923-2925 |
TO |
denotes |
to |
| T662 |
2926-2942 |
JJ |
denotes |
highly-processed |
| T663 |
2943-2955 |
JJ |
denotes |
complex-type |
| T664 |
2956-2969 |
NN |
denotes |
glycosylation |
| T665 |
2971-2974 |
DT |
denotes |
The |
| T666 |
2975-2985 |
JJ |
denotes |
structural |
| T667 |
2986-2993 |
NN |
denotes |
mapping |
| T668 |
2994-2996 |
IN |
denotes |
of |
| T669 |
2997-3004 |
NNS |
denotes |
glycans |
| T670 |
3005-3007 |
IN |
denotes |
of |
| T671 |
3008-3016 |
JJ |
denotes |
trimeric |
| T672 |
3017-3018 |
NN |
denotes |
S |
| T673 |
3019-3027 |
NNS |
denotes |
proteins |
| T674 |
3028-3036 |
VBD |
denotes |
revealed |
| T675 |
3037-3041 |
IN |
denotes |
that |
| T676 |
3042-3046 |
DT |
denotes |
some |
| T677 |
3047-3049 |
IN |
denotes |
of |
| T678 |
3050-3055 |
DT |
denotes |
these |
| T679 |
3056-3063 |
NNS |
denotes |
glycans |
| T680 |
3064-3074 |
VBP |
denotes |
contribute |
| T681 |
3075-3077 |
TO |
denotes |
to |
| T682 |
3078-3081 |
DT |
denotes |
the |
| T683 |
3082-3091 |
NN |
denotes |
formation |
| T684 |
3092-3094 |
IN |
denotes |
of |
| T685 |
3095-3096 |
DT |
denotes |
a |
| T686 |
3097-3104 |
NN |
denotes |
cluster |
| T687 |
3105-3107 |
IN |
denotes |
of |
| T688 |
3108-3125 |
JJ |
denotes |
oligomannose-type |
| T689 |
3126-3133 |
NNS |
denotes |
glycans |
| T690 |
3134-3136 |
IN |
denotes |
at |
| T691 |
3137-3145 |
JJ |
denotes |
specific |
| T692 |
3146-3153 |
NNS |
denotes |
regions |
| T693 |
3154-3156 |
IN |
denotes |
of |
| T694 |
3157-3161 |
JJ |
denotes |
high |
| T695 |
3162-3168 |
NN |
denotes |
glycan |
| T696 |
3169-3176 |
NN |
denotes |
density |
| T697 |
3177-3179 |
IN |
denotes |
on |
| T698 |
3180-3188 |
NNP |
denotes |
MERS-CoV |
| T699 |
3189-3191 |
NNP |
denotes |
S. |
| T700 |
3192-3201 |
NNP |
denotes |
Molecular |
| T701 |
3202-3211 |
NN |
denotes |
evolution |
| T702 |
3212-3220 |
NN |
denotes |
analysis |
| T703 |
3221-3223 |
IN |
denotes |
of |
| T704 |
3224-3228 |
NNP |
denotes |
SARS |
| T705 |
3229-3232 |
CC |
denotes |
and |
| T706 |
3233-3237 |
NNP |
denotes |
MERS |
| T707 |
3238-3239 |
NN |
denotes |
S |
| T708 |
3240-3245 |
NNS |
denotes |
genes |
| T709 |
3246-3250 |
RB |
denotes |
also |
| T710 |
3251-3258 |
VBZ |
denotes |
reveals |
| T711 |
3259-3260 |
DT |
denotes |
a |
| T712 |
3261-3267 |
JJR |
denotes |
higher |
| T713 |
3268-3277 |
NN |
denotes |
incidence |
| T714 |
3278-3280 |
IN |
denotes |
of |
| T715 |
3281-3291 |
JJ |
denotes |
amino-acid |
| T716 |
3292-3301 |
NN |
denotes |
diversity |
| T717 |
3302-3304 |
IN |
denotes |
on |
| T718 |
3305-3308 |
DT |
denotes |
the |
| T719 |
3309-3316 |
VBN |
denotes |
exposed |
| T720 |
3317-3325 |
NNS |
denotes |
surfaces |
| T721 |
3326-3328 |
IN |
denotes |
of |
| T722 |
3329-3332 |
DT |
denotes |
the |
| T723 |
3333-3334 |
NN |
denotes |
S |
| T724 |
3335-3343 |
NNS |
denotes |
proteins |
| T725 |
3344-3348 |
WDT |
denotes |
that |
| T726 |
3349-3352 |
VBP |
denotes |
are |
| T727 |
3353-3356 |
RB |
denotes |
not |
| T728 |
3357-3365 |
VBN |
denotes |
occluded |
| T729 |
3366-3368 |
IN |
denotes |
by |
| T730 |
3369-3377 |
JJ |
denotes |
N-linked |
| T731 |
3378-3385 |
NNS |
denotes |
glycans |
| T732 |
3387-3389 |
IN |
denotes |
In |
| T733 |
3390-3398 |
NN |
denotes |
addition |
| T734 |
3398-3399 |
-COMMA- |
denotes |
, |
| T735 |
3400-3402 |
PRP |
denotes |
we |
| T736 |
3403-3410 |
VBP |
denotes |
compare |
| T737 |
3411-3414 |
DT |
denotes |
the |
| T738 |
3415-3425 |
NNS |
denotes |
structures |
| T739 |
3426-3428 |
IN |
denotes |
of |
| T740 |
3429-3432 |
DT |
denotes |
the |
| T741 |
3433-3443 |
JJ |
denotes |
respective |
| T742 |
3444-3450 |
NN |
denotes |
glycan |
| T743 |
3451-3456 |
NNS |
denotes |
coats |
| T744 |
3457-3459 |
IN |
denotes |
of |
| T745 |
3460-3464 |
NN |
denotes |
SARS |
| T746 |
3465-3468 |
CC |
denotes |
and |
| T747 |
3469-3474 |
NN |
denotes |
HIV-1 |
| T748 |
3475-3483 |
NN |
denotes |
envelope |
| T749 |
3484-3492 |
NNS |
denotes |
proteins |
| T750 |
3493-3498 |
VBG |
denotes |
using |
| T751 |
3499-3512 |
NN |
denotes |
cryo-electron |
| T752 |
3513-3523 |
NN |
denotes |
microscopy |
| T753 |
3524-3525 |
-LRB- |
denotes |
( |
| T754 |
3525-3532 |
NN |
denotes |
cryo-EM |
| T755 |
3532-3533 |
-RRB- |
denotes |
) |
| T756 |
3534-3537 |
CC |
denotes |
and |
| T757 |
3538-3551 |
JJ |
denotes |
computational |
| T758 |
3552-3561 |
NN |
denotes |
modelling |
| T759 |
3561-3562 |
-COMMA- |
denotes |
, |
| T760 |
3563-3568 |
WDT |
denotes |
which |
| T761 |
3569-3578 |
VBP |
denotes |
delineate |
| T762 |
3579-3580 |
DT |
denotes |
a |
| T763 |
3581-3587 |
JJ |
denotes |
sparse |
| T764 |
3588-3594 |
NN |
denotes |
glycan |
| T765 |
3595-3601 |
NN |
denotes |
shield |
| T766 |
3602-3611 |
VBD |
denotes |
exhibited |
| T767 |
3612-3614 |
IN |
denotes |
on |
| T768 |
3615-3619 |
NNP |
denotes |
SARS |
| T769 |
3620-3621 |
NN |
denotes |
S |
| T770 |
3622-3630 |
VBN |
denotes |
compared |
| T771 |
3631-3635 |
IN |
denotes |
with |
| T772 |
3636-3641 |
JJ |
denotes |
other |
| T773 |
3642-3647 |
JJ |
denotes |
viral |
| T774 |
3648-3661 |
NNS |
denotes |
glycoproteins |
| T775 |
3663-3665 |
PRP |
denotes |
We |
| T776 |
3666-3675 |
RB |
denotes |
therefore |
| T777 |
3676-3685 |
VBD |
denotes |
undertook |
| T778 |
3686-3687 |
DT |
denotes |
a |
| T779 |
3688-3699 |
JJ |
denotes |
comparative |
| T780 |
3700-3708 |
NN |
denotes |
analysis |
| T781 |
3709-3711 |
IN |
denotes |
of |
| T782 |
3712-3717 |
JJ |
denotes |
viral |
| T783 |
3718-3724 |
NN |
denotes |
glycan |
| T784 |
3725-3732 |
NNS |
denotes |
shields |
| T785 |
3733-3737 |
IN |
denotes |
from |
| T786 |
3738-3751 |
VBN |
denotes |
characterized |
| T787 |
3752-3757 |
NN |
denotes |
class |
| T788 |
3758-3759 |
CD |
denotes |
I |
| T789 |
3760-3766 |
NN |
denotes |
fusion |
| T790 |
3767-3775 |
NNS |
denotes |
proteins |
| T791 |
3776-3778 |
TO |
denotes |
to |
| T792 |
3779-3788 |
VB |
denotes |
highlight |
| T793 |
3789-3792 |
WRB |
denotes |
how |
| T794 |
3793-3806 |
NN |
denotes |
glycosylation |
| T795 |
3807-3814 |
NN |
denotes |
density |
| T796 |
3815-3825 |
VBZ |
denotes |
influences |
| T797 |
3826-3843 |
JJ |
denotes |
oligomannose-type |
| T798 |
3844-3850 |
NN |
denotes |
glycan |
| T799 |
3851-3860 |
NN |
denotes |
abundance |
| T800 |
3860-3861 |
-COMMA- |
denotes |
, |
| T801 |
3862-3865 |
CC |
denotes |
and |
| T802 |
3866-3869 |
DT |
denotes |
the |
| T803 |
3870-3882 |
NN |
denotes |
relationship |
| T804 |
3883-3890 |
IN |
denotes |
between |
| T805 |
3891-3900 |
JJ |
denotes |
effective |
| T806 |
3901-3907 |
NN |
denotes |
glycan |
| T807 |
3908-3915 |
NNS |
denotes |
shields |
| T808 |
3916-3919 |
CC |
denotes |
and |
| T809 |
3920-3925 |
JJ |
denotes |
viral |
| T810 |
3926-3933 |
NN |
denotes |
evasion |
| T811 |
3934-3941 |
NN |
denotes |
ability |
| T812 |
3943-3951 |
RB |
denotes |
Together |
| T813 |
3951-3952 |
-COMMA- |
denotes |
, |
| T814 |
3953-3958 |
DT |
denotes |
these |
| T815 |
3959-3963 |
NNS |
denotes |
data |
| T816 |
3964-3974 |
VBP |
denotes |
underscore |
| T817 |
3975-3978 |
DT |
denotes |
the |
| T818 |
3979-3989 |
NN |
denotes |
importance |
| T819 |
3990-3992 |
IN |
denotes |
of |
| T820 |
3993-4006 |
NN |
denotes |
glycosylation |
| T821 |
4007-4009 |
IN |
denotes |
in |
| T822 |
4010-4015 |
JJ |
denotes |
viral |
| T823 |
4016-4022 |
JJ |
denotes |
immune |
| T824 |
4023-4030 |
NN |
denotes |
evasion |
| R221 |
T225 |
T226 |
arg1Of |
Coronaviruses,( |
| R222 |
T227 |
T226 |
arg2Of |
CoVs,( |
| R223 |
T228 |
T226 |
arg3Of |
),( |
| R224 |
T225 |
T229 |
arg1Of |
Coronaviruses,are |
| R225 |
T231 |
T229 |
arg2Of |
pathogens,are |
| R226 |
T231 |
T230 |
arg2Of |
pathogens,enveloped |
| R227 |
T231 |
T232 |
arg1Of |
pathogens,responsible |
| R228 |
T232 |
T233 |
arg1Of |
responsible,for |
| R229 |
T236 |
T233 |
arg2Of |
disorders,for |
| R230 |
T236 |
T234 |
arg1Of |
disorders,multiple |
| R231 |
T236 |
T235 |
arg1Of |
disorders,respiratory |
| R232 |
T236 |
T237 |
arg1Of |
disorders,of |
| R233 |
T239 |
T237 |
arg2Of |
severity,of |
| R234 |
T239 |
T238 |
arg1Of |
severity,varying |
| R235 |
T239 |
T240 |
arg1Of |
severity,in |
| R236 |
T241 |
T240 |
arg2Of |
humans1,in |
| R237 |
T243 |
T242 |
arg1Of |
CoVs,Certain |
| R238 |
T243 |
T244 |
arg1Of |
CoVs,represent |
| R239 |
T247 |
T244 |
arg2Of |
threat,represent |
| R240 |
T247 |
T245 |
arg1Of |
threat,a |
| R241 |
T247 |
T246 |
arg1Of |
threat,significant |
| R242 |
T247 |
T248 |
arg1Of |
threat,to |
| R243 |
T251 |
T248 |
arg2Of |
health,to |
| R244 |
T251 |
T249 |
arg1Of |
health,global |
| R245 |
T251 |
T250 |
arg1Of |
health,human |
| R246 |
T244 |
T252 |
arg1Of |
represent,"," |
| R247 |
T244 |
T253 |
arg1Of |
represent,as |
| R248 |
T254 |
T253 |
arg2Of |
illustrated,as |
| R249 |
T256 |
T254 |
arg1Of |
outbreaks,illustrated |
| R250 |
T256 |
T255 |
arg2Of |
outbreaks,by |
| R251 |
T256 |
T257 |
arg1Of |
outbreaks,of |
| R252 |
T262 |
T257 |
arg2Of |
coronavirus,of |
| R253 |
T262 |
T258 |
arg1Of |
coronavirus,severe |
| R254 |
T262 |
T259 |
arg1Of |
coronavirus,acute |
| R255 |
T262 |
T260 |
arg1Of |
coronavirus,respiratory |
| R256 |
T262 |
T261 |
arg1Of |
coronavirus,syndrome |
| R257 |
T262 |
T263 |
arg1Of |
coronavirus,( |
| R258 |
T264 |
T263 |
arg2Of |
SARS-CoV,( |
| R259 |
T265 |
T263 |
arg3Of |
),( |
| R260 |
T262 |
T266 |
arg1Of |
coronavirus,in |
| R261 |
T267 |
T266 |
arg2Of |
20032,in |
| R262 |
T256 |
T268 |
arg1Of |
outbreaks,"," |
| R263 |
T273 |
T268 |
arg2Of |
coronavirus,"," |
| R264 |
T270 |
T269 |
arg1Of |
East,Middle |
| R265 |
T273 |
T270 |
arg1Of |
coronavirus,East |
| R266 |
T273 |
T271 |
arg1Of |
coronavirus,respiratory |
| R267 |
T273 |
T272 |
arg1Of |
coronavirus,syndrome |
| R268 |
T273 |
T274 |
arg1Of |
coronavirus,( |
| R269 |
T275 |
T274 |
arg2Of |
MERS-CoV,( |
| R270 |
T276 |
T274 |
arg3Of |
),( |
| R271 |
T273 |
T277 |
arg1Of |
coronavirus,in |
| R272 |
T278 |
T277 |
arg2Of |
20123,in |
| R273 |
T280 |
T279 |
arg1Of |
and,"," |
| R274 |
T277 |
T280 |
arg1Of |
in,and |
| R275 |
T283 |
T280 |
arg2Of |
of,and |
| R276 |
T282 |
T281 |
arg1Of |
recently,most |
| R277 |
T283 |
T282 |
arg1Of |
of,recently |
| R278 |
T273 |
T283 |
arg1Of |
coronavirus,of |
| R279 |
T284 |
T283 |
arg2Of |
SARS-CoV-24,of |
| R280 |
T313 |
T285 |
arg1Of |
is,Given |
| R281 |
T300 |
T285 |
arg2Of |
and,Given |
| R282 |
T288 |
T286 |
arg1Of |
rates,their |
| R283 |
T288 |
T287 |
arg1Of |
rates,mortality |
| R284 |
T288 |
T289 |
arg1Of |
rates,"," |
| R285 |
T292 |
T289 |
arg2Of |
lack,"," |
| R286 |
T292 |
T290 |
arg1Of |
lack,the |
| R287 |
T292 |
T291 |
arg1Of |
lack,current |
| R288 |
T292 |
T293 |
arg1Of |
lack,of |
| R289 |
T296 |
T293 |
arg2Of |
and,of |
| R290 |
T295 |
T294 |
arg2Of |
treatments,targeted |
| R291 |
T295 |
T296 |
arg1Of |
treatments,and |
| R292 |
T298 |
T296 |
arg2Of |
vaccines,and |
| R293 |
T298 |
T297 |
arg1Of |
vaccines,licensed |
| R294 |
T300 |
T299 |
arg1Of |
and,"," |
| R295 |
T289 |
T300 |
arg1Of |
",",and |
| R296 |
T302 |
T300 |
arg2Of |
capacity,and |
| R297 |
T302 |
T301 |
arg1Of |
capacity,their |
| R298 |
T304 |
T303 |
arg1Of |
transmit,to |
| R299 |
T302 |
T303 |
modOf |
capacity,to |
| R300 |
T304 |
T305 |
arg1Of |
transmit,between |
| R301 |
T306 |
T305 |
arg2Of |
humans,between |
| R302 |
T285 |
T307 |
arg1Of |
Given,and |
| R303 |
T308 |
T307 |
arg2Of |
across,and |
| R304 |
T313 |
T308 |
arg1Of |
is,across |
| R305 |
T310 |
T308 |
arg2Of |
"barriers5,6",across |
| R306 |
T310 |
T309 |
arg1Of |
"barriers5,6",species |
| R307 |
T313 |
T311 |
arg1Of |
is,"," |
| R308 |
T312 |
T313 |
arg1Of |
there,is |
| R309 |
T316 |
T313 |
arg2Of |
need,is |
| R310 |
T316 |
T314 |
arg1Of |
need,an |
| R311 |
T316 |
T315 |
arg1Of |
need,urgent |
| R312 |
T316 |
T317 |
arg1Of |
need,for |
| R313 |
T319 |
T317 |
arg2Of |
countermeasures,for |
| R314 |
T321 |
T317 |
arg3Of |
combat,for |
| R315 |
T319 |
T318 |
arg1Of |
countermeasures,effective |
| R316 |
T321 |
T320 |
arg1Of |
combat,to |
| R317 |
T319 |
T321 |
arg1Of |
countermeasures,combat |
| R318 |
T323 |
T321 |
arg2Of |
pathogens,combat |
| R319 |
T323 |
T322 |
arg1Of |
pathogens,these |
| R320 |
T328 |
T324 |
arg1Of |
focus,Ongoing |
| R321 |
T328 |
T325 |
arg1Of |
focus,vaccine |
| R322 |
T328 |
T326 |
arg1Of |
focus,development |
| R323 |
T328 |
T327 |
arg1Of |
focus,efforts |
| R324 |
T328 |
T329 |
arg1Of |
focus,on |
| R325 |
T335 |
T329 |
arg2Of |
proteins,on |
| R326 |
T335 |
T330 |
arg1Of |
proteins,the |
| R327 |
T335 |
T331 |
arg1Of |
proteins,spike |
| R328 |
T335 |
T332 |
arg1Of |
proteins,( |
| R329 |
T333 |
T332 |
arg2Of |
S,( |
| R330 |
T334 |
T332 |
arg3Of |
),( |
| R331 |
T335 |
T336 |
arg1Of |
proteins,that |
| R332 |
T335 |
T337 |
arg1Of |
proteins,protrude |
| R333 |
T337 |
T338 |
arg1Of |
protrude,from |
| R334 |
T341 |
T338 |
arg2Of |
envelope,from |
| R335 |
T341 |
T339 |
arg1Of |
envelope,the |
| R336 |
T341 |
T340 |
arg1Of |
envelope,viral |
| R337 |
T337 |
T342 |
arg1Of |
protrude,and |
| R338 |
T343 |
T342 |
arg2Of |
constitute,and |
| R339 |
T335 |
T343 |
arg1Of |
proteins,constitute |
| R340 |
T346 |
T343 |
arg2Of |
target,constitute |
| R341 |
T346 |
T344 |
arg1Of |
target,the |
| R342 |
T346 |
T345 |
arg1Of |
target,main |
| R343 |
T346 |
T347 |
arg1Of |
target,of |
| R344 |
T348 |
T347 |
arg2Of |
neutralizing,of |
| R345 |
T349 |
T348 |
arg2Of |
"antibodies7,8",neutralizing |
| R346 |
T353 |
T350 |
arg1Of |
proteins,These |
| R347 |
T353 |
T351 |
arg1Of |
proteins,trimeric |
| R348 |
T353 |
T352 |
arg1Of |
proteins,S |
| R349 |
T353 |
T354 |
arg1Of |
proteins,mediate |
| R350 |
T356 |
T354 |
arg2Of |
entry,mediate |
| R351 |
T356 |
T355 |
arg1Of |
entry,host-cell |
| R352 |
T354 |
T357 |
arg1Of |
mediate,with |
| R353 |
T362 |
T357 |
arg2Of |
subunits,with |
| R354 |
T362 |
T358 |
arg1Of |
subunits,the |
| R355 |
T362 |
T359 |
arg1Of |
subunits,S1 |
| R356 |
T359 |
T360 |
arg1Of |
S1,and |
| R357 |
T361 |
T360 |
arg2Of |
S2,and |
| R358 |
T362 |
T361 |
arg1Of |
subunits,S2 |
| R359 |
T362 |
T363 |
arg1Of |
subunits,responsible |
| R360 |
T363 |
T364 |
arg1Of |
responsible,for |
| R361 |
T370 |
T364 |
arg2Of |
and,for |
| R362 |
T365 |
T366 |
arg1Of |
binding,to |
| R363 |
T369 |
T366 |
arg2Of |
receptor,to |
| R364 |
T369 |
T367 |
arg1Of |
receptor,the |
| R365 |
T369 |
T368 |
arg1Of |
receptor,host-cell |
| R366 |
T365 |
T370 |
arg1Of |
binding,and |
| R367 |
T371 |
T370 |
arg2Of |
facilitating,and |
| R368 |
T373 |
T371 |
arg2Of |
fusion,facilitating |
| R369 |
T373 |
T372 |
arg1Of |
fusion,membrane |
| R370 |
T362 |
T374 |
arg1Of |
subunits,"," |
| R371 |
T375 |
T374 |
arg2Of |
respectively9–11,"," |
| R372 |
T377 |
T376 |
arg1Of |
S,MERS |
| R373 |
T377 |
T378 |
arg1Of |
S,binds |
| R374 |
T378 |
T379 |
arg1Of |
binds,to |
| R375 |
T380 |
T379 |
arg2Of |
dipeptidyl-peptidase,to |
| R376 |
T380 |
T381 |
arg1Of |
dipeptidyl-peptidase,4 |
| R377 |
T380 |
T382 |
arg1Of |
dipeptidyl-peptidase,( |
| R378 |
T383 |
T382 |
arg2Of |
DPP4,( |
| R379 |
T384 |
T382 |
arg3Of |
),( |
| R380 |
T380 |
T385 |
arg1Of |
dipeptidyl-peptidase,12 |
| R381 |
T378 |
T386 |
arg1Of |
binds,"," |
| R382 |
T378 |
T387 |
arg1Of |
binds,whereas |
| R383 |
T392 |
T387 |
arg2Of |
utilize,whereas |
| R384 |
T389 |
T388 |
arg1Of |
S13,SARS |
| R385 |
T389 |
T390 |
arg1Of |
S13,and |
| R386 |
T391 |
T390 |
arg2Of |
"SARS-CoV-214,15",and |
| R387 |
T390 |
T392 |
arg1Of |
and,utilize |
| R388 |
T394 |
T392 |
arg2Of |
enzyme,utilize |
| R389 |
T394 |
T393 |
arg1Of |
enzyme,angiotensin-converting |
| R390 |
T394 |
T395 |
arg1Of |
enzyme,2 |
| R391 |
T394 |
T396 |
arg1Of |
enzyme,( |
| R392 |
T397 |
T396 |
arg2Of |
ACE2,( |
| R393 |
T398 |
T396 |
arg3Of |
),( |
| R394 |
T392 |
T399 |
arg1Of |
utilize,as |
| R395 |
T403 |
T399 |
arg2Of |
receptor,as |
| R396 |
T403 |
T400 |
arg1Of |
receptor,a |
| R397 |
T403 |
T401 |
arg1Of |
receptor,host |
| R398 |
T403 |
T402 |
arg1Of |
receptor,cellular |
| R399 |
T406 |
T404 |
arg1Of |
proteins,CoV |
| R400 |
T406 |
T405 |
arg1Of |
proteins,S |
| R401 |
T406 |
T407 |
arg1Of |
proteins,are |
| R402 |
T415 |
T407 |
arg2Of |
known9,are |
| R403 |
T415 |
T408 |
arg1Of |
known9,the |
| R404 |
T415 |
T409 |
arg1Of |
known9,largest |
| R405 |
T415 |
T410 |
arg1Of |
known9,class |
| R406 |
T415 |
T411 |
arg1Of |
known9,I |
| R407 |
T415 |
T412 |
arg1Of |
known9,viral |
| R408 |
T415 |
T413 |
arg1Of |
known9,fusion |
| R409 |
T415 |
T414 |
arg1Of |
known9,proteins |
| R410 |
T417 |
T416 |
arg1Of |
and,"," |
| R411 |
T407 |
T417 |
arg1Of |
are,and |
| R412 |
T420 |
T417 |
arg2Of |
glycosylated,and |
| R413 |
T406 |
T418 |
arg1Of |
proteins,are |
| R414 |
T420 |
T418 |
arg2Of |
glycosylated,are |
| R415 |
T420 |
T419 |
arg1Of |
glycosylated,extensively |
| R416 |
T406 |
T420 |
arg2Of |
proteins,glycosylated |
| R417 |
T420 |
T421 |
arg1Of |
glycosylated,"," |
| R418 |
T420 |
T422 |
arg1Of |
glycosylated,with |
| R419 |
T427 |
T422 |
arg2Of |
glycoproteins,with |
| R420 |
T427 |
T423 |
arg1Of |
glycoproteins,SARS |
| R421 |
T423 |
T424 |
arg1Of |
SARS,and |
| R422 |
T425 |
T424 |
arg2Of |
MERS,and |
| R423 |
T427 |
T425 |
arg1Of |
glycoproteins,MERS |
| R424 |
T427 |
T426 |
arg1Of |
glycoproteins,S |
| R425 |
T429 |
T428 |
arg1Of |
encoding,both |
| R426 |
T427 |
T429 |
arg1Of |
glycoproteins,encoding |
| R427 |
T433 |
T429 |
arg2Of |
sequons,encoding |
| R428 |
T433 |
T430 |
arg1Of |
sequons,69 |
| R429 |
T433 |
T431 |
arg1Of |
sequons,N-linked |
| R430 |
T433 |
T432 |
arg1Of |
sequons,glycan |
| R431 |
T433 |
T434 |
arg1Of |
sequons,per |
| R432 |
T436 |
T434 |
arg2Of |
spike,per |
| R433 |
T436 |
T435 |
arg1Of |
spike,trimeric |
| R434 |
T436 |
T437 |
arg1Of |
spike,with |
| R435 |
T438 |
T437 |
arg2Of |
SARS-CoV-2,with |
| R436 |
T438 |
T439 |
arg1Of |
SARS-CoV-2,containing |
| R437 |
T441 |
T439 |
arg2Of |
sites,containing |
| R438 |
T441 |
T440 |
arg1Of |
sites,66 |
| R439 |
T443 |
T442 |
arg1Of |
modifications,These |
| R440 |
T445 |
T444 |
arg1Of |
mask,often |
| R441 |
T443 |
T445 |
arg1Of |
modifications,mask |
| R442 |
T448 |
T445 |
arg2Of |
epitopes,mask |
| R443 |
T448 |
T446 |
arg1Of |
epitopes,immunogenic |
| R444 |
T448 |
T447 |
arg1Of |
epitopes,protein |
| R445 |
T448 |
T449 |
arg1Of |
epitopes,from |
| R446 |
T454 |
T449 |
arg2Of |
system,from |
| R447 |
T454 |
T450 |
arg1Of |
system,the |
| R448 |
T454 |
T451 |
arg1Of |
system,host |
| R449 |
T454 |
T452 |
arg1Of |
system,humoral |
| R450 |
T454 |
T453 |
arg1Of |
system,immune |
| R451 |
T445 |
T455 |
arg1Of |
mask,by |
| R452 |
T456 |
T455 |
arg2Of |
occluding,by |
| R453 |
T443 |
T456 |
arg1Of |
modifications,occluding |
| R454 |
T457 |
T456 |
arg2Of |
them,occluding |
| R455 |
T456 |
T458 |
arg1Of |
occluding,with |
| R456 |
T460 |
T458 |
arg2Of |
glycans16–18,with |
| R457 |
T460 |
T459 |
arg1Of |
glycans16–18,host-derived |
| R458 |
T462 |
T461 |
arg1Of |
phenomenon,This |
| R459 |
T462 |
T463 |
arg1Of |
phenomenon,of |
| R460 |
T465 |
T463 |
arg2Of |
evasion,of |
| R461 |
T465 |
T464 |
arg1Of |
evasion,immune |
| R462 |
T462 |
T466 |
arg1Of |
phenomenon,by |
| R463 |
T469 |
T466 |
arg2Of |
and,by |
| R464 |
T468 |
T467 |
arg1Of |
mimicry,molecular |
| R465 |
T468 |
T469 |
arg1Of |
mimicry,and |
| R466 |
T471 |
T469 |
arg2Of |
shielding,and |
| R467 |
T471 |
T470 |
arg1Of |
shielding,glycan |
| R468 |
T462 |
T472 |
arg1Of |
phenomenon,has |
| R469 |
T475 |
T472 |
arg2Of |
characterised,has |
| R470 |
T462 |
T473 |
arg1Of |
phenomenon,been |
| R471 |
T475 |
T473 |
arg2Of |
characterised,been |
| R472 |
T475 |
T474 |
arg1Of |
characterised,well |
| R473 |
T462 |
T475 |
arg2Of |
phenomenon,characterised |
| R474 |
T475 |
T476 |
arg1Of |
characterised,across |
| R475 |
T479 |
T476 |
arg2Of |
glycoproteins,across |
| R476 |
T479 |
T477 |
arg1Of |
glycoproteins,other |
| R477 |
T479 |
T478 |
arg1Of |
glycoproteins,viral |
| R478 |
T479 |
T480 |
arg1Of |
glycoproteins,"," |
| R479 |
T482 |
T481 |
arg1Of |
as,such |
| R480 |
T479 |
T482 |
arg1Of |
glycoproteins,as |
| R481 |
T497 |
T482 |
arg2Of |
and,as |
| R482 |
T485 |
T483 |
arg1Of |
protein,HIV-1 |
| R483 |
T485 |
T484 |
arg1Of |
protein,envelope |
| R484 |
T492 |
T485 |
arg1Of |
hemagglutinin,protein |
| R485 |
T485 |
T486 |
arg1Of |
protein,( |
| R486 |
T487 |
T486 |
arg2Of |
Env,( |
| R487 |
T488 |
T486 |
arg3Of |
),( |
| R488 |
T485 |
T489 |
arg1Of |
protein,19–21 |
| R489 |
T485 |
T490 |
arg1Of |
protein,"," |
| R490 |
T491 |
T490 |
arg2Of |
influenza,"," |
| R491 |
T492 |
T491 |
arg1Of |
hemagglutinin,influenza |
| R492 |
T492 |
T493 |
arg1Of |
hemagglutinin,( |
| R493 |
T494 |
T493 |
arg2Of |
HA,( |
| R494 |
T495 |
T493 |
arg3Of |
),( |
| R495 |
T492 |
T496 |
arg1Of |
hemagglutinin,"22,23" |
| R496 |
T492 |
T497 |
arg1Of |
hemagglutinin,and |
| R497 |
T501 |
T497 |
arg2Of |
complex,and |
| R498 |
T501 |
T498 |
arg1Of |
complex,Lassa |
| R499 |
T501 |
T499 |
arg1Of |
complex,virus |
| R500 |
T501 |
T500 |
arg1Of |
complex,glycoprotein |
| R501 |
T501 |
T502 |
arg1Of |
complex,( |
| R502 |
T504 |
T502 |
arg2Of |
GPC,( |
| R503 |
T505 |
T502 |
arg3Of |
),( |
| R504 |
T504 |
T503 |
arg1Of |
GPC,LASV |
| R505 |
T501 |
T506 |
arg1Of |
complex,24–26 |
| R506 |
T508 |
T507 |
arg1Of |
analyses,Previous |
| R507 |
T508 |
T509 |
arg1Of |
analyses,of |
| R508 |
T512 |
T509 |
arg2Of |
shields,of |
| R509 |
T512 |
T510 |
arg1Of |
shields,viral |
| R510 |
T512 |
T511 |
arg1Of |
shields,glycan |
| R511 |
T508 |
T513 |
arg1Of |
analyses,have |
| R512 |
T514 |
T513 |
arg2Of |
revealed,have |
| R513 |
T508 |
T514 |
arg1Of |
analyses,revealed |
| R514 |
T516 |
T514 |
arg2Of |
presence,revealed |
| R515 |
T516 |
T515 |
arg1Of |
presence,the |
| R516 |
T516 |
T517 |
arg1Of |
presence,of |
| R517 |
T520 |
T517 |
arg2Of |
glycans,of |
| R518 |
T520 |
T518 |
arg1Of |
glycans,underprocessed |
| R519 |
T520 |
T519 |
arg1Of |
glycans,oligomannose-type |
| R520 |
T520 |
T521 |
arg1Of |
glycans,that |
| R521 |
T523 |
T522 |
arg1Of |
arise,seemingly |
| R522 |
T520 |
T523 |
arg1Of |
glycans,arise |
| R523 |
T525 |
T524 |
arg1Of |
to,due |
| R524 |
T523 |
T525 |
arg1Of |
arise,to |
| R525 |
T527 |
T525 |
arg2Of |
constraints,to |
| R526 |
T527 |
T526 |
arg1Of |
constraints,steric |
| R527 |
T527 |
T528 |
arg1Of |
constraints,that |
| R528 |
T527 |
T529 |
arg1Of |
constraints,prevent |
| R529 |
T530 |
T529 |
arg2Of |
access,prevent |
| R530 |
T530 |
T531 |
arg1Of |
access,of |
| R531 |
T534 |
T531 |
arg2Of |
enzymes,of |
| R532 |
T534 |
T532 |
arg1Of |
enzymes,glycan |
| R533 |
T534 |
T533 |
arg1Of |
enzymes,processing |
| R534 |
T530 |
T535 |
arg1Of |
access,to |
| R535 |
T537 |
T535 |
arg2Of |
"glycans24,27,28",to |
| R536 |
T537 |
T536 |
arg1Of |
"glycans24,27,28",substrate |
| R537 |
T523 |
T538 |
arg1Of |
arise,"," |
| R538 |
T523 |
T539 |
arg1Of |
arise,especially |
| R539 |
T545 |
T539 |
arg2Of |
evolved,especially |
| R540 |
T539 |
T540 |
arg1Of |
especially,when |
| R541 |
T543 |
T541 |
arg1Of |
glycoprotein,the |
| R542 |
T543 |
T542 |
arg1Of |
glycoprotein,viral |
| R543 |
T543 |
T544 |
arg1Of |
glycoprotein,has |
| R544 |
T545 |
T544 |
arg2Of |
evolved,has |
| R545 |
T543 |
T545 |
arg1Of |
glycoprotein,evolved |
| R546 |
T547 |
T545 |
arg2Of |
mask,evolved |
| R547 |
T547 |
T546 |
arg1Of |
mask,to |
| R548 |
T543 |
T547 |
arg1Of |
glycoprotein,mask |
| R549 |
T549 |
T547 |
arg2Of |
epitopes,mask |
| R550 |
T549 |
T548 |
arg1Of |
epitopes,immunogenic |
| R551 |
T547 |
T550 |
arg1Of |
mask,with |
| R552 |
T554 |
T550 |
arg2Of |
array,with |
| R553 |
T554 |
T551 |
arg1Of |
array,a |
| R554 |
T553 |
T552 |
arg1Of |
dense,particularly |
| R555 |
T554 |
T553 |
arg1Of |
array,dense |
| R556 |
T554 |
T555 |
arg1Of |
array,of |
| R557 |
T557 |
T555 |
arg2Of |
"glycans26,29–34",of |
| R558 |
T557 |
T556 |
arg1Of |
"glycans26,29–34",host-derived |
| R559 |
T559 |
T558 |
arg1Of |
access,Restricted |
| R560 |
T559 |
T560 |
arg1Of |
access,to |
| R561 |
T563 |
T560 |
arg2Of |
sites,to |
| R562 |
T563 |
T561 |
arg1Of |
sites,these |
| R563 |
T563 |
T562 |
arg1Of |
sites,glycan |
| R564 |
T559 |
T564 |
arg1Of |
access,or |
| R565 |
T565 |
T564 |
arg2Of |
interference,or |
| R566 |
T565 |
T566 |
arg1Of |
interference,with |
| R567 |
T570 |
T566 |
arg2Of |
or,with |
| R568 |
T569 |
T567 |
arg1Of |
surface,surrounding |
| R569 |
T569 |
T568 |
arg1Of |
surface,protein |
| R570 |
T569 |
T570 |
arg1Of |
surface,or |
| R571 |
T573 |
T570 |
arg2Of |
residues,or |
| R572 |
T573 |
T571 |
arg1Of |
residues,neighbouring |
| R573 |
T573 |
T572 |
arg1Of |
residues,glycan |
| R574 |
T564 |
T574 |
arg1Of |
or,can |
| R575 |
T575 |
T574 |
arg2Of |
render,can |
| R576 |
T564 |
T575 |
arg1Of |
or,render |
| R577 |
T578 |
T575 |
arg2Of |
enzymes,render |
| R578 |
T578 |
T576 |
arg1Of |
enzymes,glycan |
| R579 |
T578 |
T577 |
arg1Of |
enzymes,processing |
| R580 |
T578 |
T579 |
arg1Of |
enzymes,ineffective |
| R581 |
T579 |
T580 |
arg1Of |
ineffective,in |
| R582 |
T582 |
T580 |
arg2Of |
"regions27,28,35",in |
| R583 |
T582 |
T581 |
arg1Of |
"regions27,28,35",specific |
| R584 |
T584 |
T583 |
arg1Of |
processing,Glycan |
| R585 |
T584 |
T585 |
arg1Of |
processing,on |
| R586 |
T587 |
T585 |
arg2Of |
glycoproteins,on |
| R587 |
T587 |
T586 |
arg1Of |
glycoproteins,soluble |
| R588 |
T584 |
T588 |
arg1Of |
processing,has |
| R589 |
T591 |
T588 |
arg2Of |
shown,has |
| R590 |
T591 |
T589 |
arg1Of |
shown,also |
| R591 |
T584 |
T590 |
arg1Of |
processing,been |
| R592 |
T591 |
T590 |
arg2Of |
shown,been |
| R593 |
T584 |
T591 |
arg2Of |
processing,shown |
| R594 |
T593 |
T591 |
arg3Of |
be,shown |
| R595 |
T593 |
T592 |
arg1Of |
be,to |
| R596 |
T584 |
T593 |
arg1Of |
processing,be |
| R597 |
T596 |
T593 |
arg2Of |
reporter,be |
| R598 |
T596 |
T594 |
arg1Of |
reporter,a |
| R599 |
T596 |
T595 |
arg1Of |
reporter,strong |
| R600 |
T596 |
T597 |
arg1Of |
reporter,of |
| R601 |
T600 |
T597 |
arg2Of |
architecture,of |
| R602 |
T600 |
T598 |
arg1Of |
architecture,native-like |
| R603 |
T600 |
T599 |
arg1Of |
architecture,protein |
| R604 |
T591 |
T601 |
arg1Of |
shown,and |
| R605 |
T616 |
T601 |
arg2Of |
mimic,and |
| R606 |
T616 |
T602 |
arg1Of |
mimic,thus |
| R607 |
T604 |
T603 |
arg1Of |
integrity36–38,immunogen |
| R608 |
T606 |
T605 |
arg1Of |
and,; |
| R609 |
T604 |
T606 |
arg1Of |
integrity36–38,and |
| R610 |
T608 |
T606 |
arg2Of |
processing,and |
| R611 |
T608 |
T607 |
arg1Of |
processing,glycan |
| R612 |
T606 |
T609 |
arg1Of |
and,on |
| R613 |
T613 |
T609 |
arg2Of |
candidate,on |
| R614 |
T613 |
T610 |
arg1Of |
candidate,a |
| R615 |
T613 |
T611 |
arg1Of |
candidate,successful |
| R616 |
T613 |
T612 |
arg1Of |
candidate,immunogen |
| R617 |
T606 |
T614 |
arg1Of |
and,should |
| R618 |
T616 |
T614 |
arg2Of |
mimic,should |
| R619 |
T616 |
T615 |
arg1Of |
mimic,therefore |
| R620 |
T606 |
T616 |
arg1Of |
and,mimic |
| R621 |
T625 |
T616 |
arg2Of |
features,mimic |
| R622 |
T616 |
T617 |
arg1Of |
mimic,"," |
| R623 |
T619 |
T618 |
arg1Of |
closely,as |
| R624 |
T616 |
T619 |
arg1Of |
mimic,closely |
| R625 |
T619 |
T620 |
arg1Of |
closely,as |
| R626 |
T621 |
T620 |
arg2Of |
possible,as |
| R627 |
T616 |
T622 |
arg1Of |
mimic,"," |
| R628 |
T625 |
T623 |
arg1Of |
features,the |
| R629 |
T625 |
T624 |
arg1Of |
features,structural |
| R630 |
T625 |
T626 |
arg2Of |
features,observed |
| R631 |
T626 |
T627 |
arg1Of |
observed,on |
| R632 |
T630 |
T627 |
arg2Of |
"virus39,40",on |
| R633 |
T630 |
T628 |
arg1Of |
"virus39,40",the |
| R634 |
T630 |
T629 |
arg1Of |
"virus39,40",native |
| R635 |
T652 |
T631 |
arg1Of |
and,Here |
| R636 |
T652 |
T632 |
arg1Of |
and,"," |
| R637 |
T633 |
T634 |
arg1Of |
we,provide |
| R638 |
T638 |
T634 |
arg2Of |
analyses,provide |
| R639 |
T638 |
T635 |
arg1Of |
analyses,global |
| R640 |
T635 |
T636 |
arg1Of |
global,and |
| R641 |
T637 |
T636 |
arg2Of |
site-specific,and |
| R642 |
T638 |
T637 |
arg1Of |
analyses,site-specific |
| R643 |
T638 |
T639 |
arg1Of |
analyses,of |
| R644 |
T641 |
T639 |
arg2Of |
glycosylation,of |
| R645 |
T641 |
T640 |
arg1Of |
glycosylation,N-linked |
| R646 |
T634 |
T642 |
arg1Of |
provide,on |
| R647 |
T647 |
T642 |
arg2Of |
and,on |
| R648 |
T644 |
T643 |
arg1Of |
SARS,soluble |
| R649 |
T644 |
T645 |
arg1Of |
SARS,"," |
| R650 |
T646 |
T645 |
arg2Of |
MERS,"," |
| R651 |
T645 |
T647 |
arg1Of |
",",and |
| R652 |
T651 |
T647 |
arg2Of |
glycoproteins,and |
| R653 |
T651 |
T648 |
arg1Of |
glycoproteins,HKU1 |
| R654 |
T651 |
T649 |
arg1Of |
glycoproteins,CoV |
| R655 |
T651 |
T650 |
arg1Of |
glycoproteins,S |
| R656 |
T634 |
T652 |
arg1Of |
provide,and |
| R657 |
T653 |
T652 |
arg2Of |
reveal,and |
| R658 |
T633 |
T653 |
arg1Of |
we,reveal |
| R659 |
T655 |
T653 |
arg2Of |
heterogeneity,reveal |
| R660 |
T655 |
T654 |
arg1Of |
heterogeneity,extensive |
| R661 |
T655 |
T656 |
arg1Of |
heterogeneity,"," |
| R662 |
T655 |
T657 |
arg1Of |
heterogeneity,ranging |
| R663 |
T657 |
T658 |
arg1Of |
ranging,from |
| R664 |
T660 |
T658 |
arg2Of |
glycans,from |
| R665 |
T660 |
T659 |
arg1Of |
glycans,oligomannose-type |
| R666 |
T655 |
T661 |
arg1Of |
heterogeneity,to |
| R667 |
T664 |
T661 |
arg2Of |
glycosylation,to |
| R668 |
T664 |
T662 |
arg1Of |
glycosylation,highly-processed |
| R669 |
T664 |
T663 |
arg1Of |
glycosylation,complex-type |
| R670 |
T667 |
T665 |
arg1Of |
mapping,The |
| R671 |
T667 |
T666 |
arg1Of |
mapping,structural |
| R672 |
T667 |
T668 |
arg1Of |
mapping,of |
| R673 |
T669 |
T668 |
arg2Of |
glycans,of |
| R674 |
T669 |
T670 |
arg1Of |
glycans,of |
| R675 |
T673 |
T670 |
arg2Of |
proteins,of |
| R676 |
T673 |
T671 |
arg1Of |
proteins,trimeric |
| R677 |
T673 |
T672 |
arg1Of |
proteins,S |
| R678 |
T667 |
T674 |
arg1Of |
mapping,revealed |
| R679 |
T680 |
T674 |
arg2Of |
contribute,revealed |
| R680 |
T680 |
T675 |
arg1Of |
contribute,that |
| R681 |
T676 |
T677 |
arg1Of |
some,of |
| R682 |
T679 |
T677 |
arg2Of |
glycans,of |
| R683 |
T679 |
T678 |
arg1Of |
glycans,these |
| R684 |
T676 |
T680 |
arg1Of |
some,contribute |
| R685 |
T680 |
T681 |
arg1Of |
contribute,to |
| R686 |
T683 |
T681 |
arg2Of |
formation,to |
| R687 |
T683 |
T682 |
arg1Of |
formation,the |
| R688 |
T683 |
T684 |
arg1Of |
formation,of |
| R689 |
T686 |
T684 |
arg2Of |
cluster,of |
| R690 |
T686 |
T685 |
arg1Of |
cluster,a |
| R691 |
T686 |
T687 |
arg1Of |
cluster,of |
| R692 |
T689 |
T687 |
arg2Of |
glycans,of |
| R693 |
T689 |
T688 |
arg1Of |
glycans,oligomannose-type |
| R694 |
T680 |
T690 |
arg1Of |
contribute,at |
| R695 |
T692 |
T690 |
arg2Of |
regions,at |
| R696 |
T692 |
T691 |
arg1Of |
regions,specific |
| R697 |
T692 |
T693 |
arg1Of |
regions,of |
| R698 |
T696 |
T693 |
arg2Of |
density,of |
| R699 |
T696 |
T694 |
arg1Of |
density,high |
| R700 |
T696 |
T695 |
arg1Of |
density,glycan |
| R701 |
T680 |
T697 |
arg1Of |
contribute,on |
| R702 |
T710 |
T697 |
arg2Of |
reveals,on |
| R703 |
T700 |
T698 |
arg1Of |
Molecular,MERS-CoV |
| R704 |
T700 |
T699 |
arg1Of |
Molecular,S. |
| R705 |
T702 |
T700 |
arg1Of |
analysis,Molecular |
| R706 |
T702 |
T701 |
arg1Of |
analysis,evolution |
| R707 |
T702 |
T703 |
arg1Of |
analysis,of |
| R708 |
T708 |
T703 |
arg2Of |
genes,of |
| R709 |
T708 |
T704 |
arg1Of |
genes,SARS |
| R710 |
T704 |
T705 |
arg1Of |
SARS,and |
| R711 |
T706 |
T705 |
arg2Of |
MERS,and |
| R712 |
T708 |
T706 |
arg1Of |
genes,MERS |
| R713 |
T708 |
T707 |
arg1Of |
genes,S |
| R714 |
T710 |
T709 |
arg1Of |
reveals,also |
| R715 |
T702 |
T710 |
arg1Of |
analysis,reveals |
| R716 |
T713 |
T710 |
arg2Of |
incidence,reveals |
| R717 |
T713 |
T711 |
arg1Of |
incidence,a |
| R718 |
T713 |
T712 |
arg1Of |
incidence,higher |
| R719 |
T713 |
T714 |
arg1Of |
incidence,of |
| R720 |
T716 |
T714 |
arg2Of |
diversity,of |
| R721 |
T716 |
T715 |
arg1Of |
diversity,amino-acid |
| R722 |
T710 |
T717 |
arg1Of |
reveals,on |
| R723 |
T720 |
T717 |
arg2Of |
surfaces,on |
| R724 |
T720 |
T718 |
arg1Of |
surfaces,the |
| R725 |
T720 |
T719 |
arg2Of |
surfaces,exposed |
| R726 |
T720 |
T721 |
arg1Of |
surfaces,of |
| R727 |
T724 |
T721 |
arg2Of |
proteins,of |
| R728 |
T724 |
T722 |
arg1Of |
proteins,the |
| R729 |
T724 |
T723 |
arg1Of |
proteins,S |
| R730 |
T720 |
T725 |
arg1Of |
surfaces,that |
| R731 |
T720 |
T726 |
arg1Of |
surfaces,are |
| R732 |
T728 |
T726 |
arg2Of |
occluded,are |
| R733 |
T728 |
T727 |
arg1Of |
occluded,not |
| R734 |
T731 |
T728 |
arg1Of |
glycans,occluded |
| R735 |
T720 |
T728 |
arg2Of |
surfaces,occluded |
| R736 |
T731 |
T729 |
arg2Of |
glycans,by |
| R737 |
T731 |
T730 |
arg1Of |
glycans,N-linked |
| R738 |
T746 |
T732 |
arg1Of |
and,In |
| R739 |
T733 |
T732 |
arg2Of |
addition,In |
| R740 |
T746 |
T734 |
arg1Of |
and,"," |
| R741 |
T735 |
T736 |
arg1Of |
we,compare |
| R742 |
T738 |
T736 |
arg2Of |
structures,compare |
| R743 |
T738 |
T737 |
arg1Of |
structures,the |
| R744 |
T738 |
T739 |
arg1Of |
structures,of |
| R745 |
T743 |
T739 |
arg2Of |
coats,of |
| R746 |
T743 |
T740 |
arg1Of |
coats,the |
| R747 |
T743 |
T741 |
arg1Of |
coats,respective |
| R748 |
T743 |
T742 |
arg1Of |
coats,glycan |
| R749 |
T743 |
T744 |
arg1Of |
coats,of |
| R750 |
T745 |
T744 |
arg2Of |
SARS,of |
| R751 |
T736 |
T746 |
arg1Of |
compare,and |
| R752 |
T766 |
T746 |
arg2Of |
exhibited,and |
| R753 |
T749 |
T747 |
arg1Of |
proteins,HIV-1 |
| R754 |
T749 |
T748 |
arg1Of |
proteins,envelope |
| R755 |
T749 |
T750 |
arg1Of |
proteins,using |
| R756 |
T756 |
T750 |
arg2Of |
and,using |
| R757 |
T752 |
T751 |
arg1Of |
microscopy,cryo-electron |
| R758 |
T752 |
T753 |
arg1Of |
microscopy,( |
| R759 |
T754 |
T753 |
arg2Of |
cryo-EM,( |
| R760 |
T755 |
T753 |
arg3Of |
),( |
| R761 |
T752 |
T756 |
arg1Of |
microscopy,and |
| R762 |
T758 |
T756 |
arg2Of |
modelling,and |
| R763 |
T758 |
T757 |
arg1Of |
modelling,computational |
| R764 |
T758 |
T759 |
arg1Of |
modelling,"," |
| R765 |
T758 |
T760 |
arg1Of |
modelling,which |
| R766 |
T758 |
T761 |
arg1Of |
modelling,delineate |
| R767 |
T765 |
T761 |
arg2Of |
shield,delineate |
| R768 |
T765 |
T762 |
arg1Of |
shield,a |
| R769 |
T765 |
T763 |
arg1Of |
shield,sparse |
| R770 |
T765 |
T764 |
arg1Of |
shield,glycan |
| R771 |
T749 |
T766 |
arg1Of |
proteins,exhibited |
| R772 |
T769 |
T766 |
arg2Of |
S,exhibited |
| R773 |
T766 |
T767 |
arg1Of |
exhibited,on |
| R774 |
T768 |
T767 |
arg2Of |
SARS,on |
| R775 |
T766 |
T770 |
arg1Of |
exhibited,compared |
| R776 |
T771 |
T770 |
arg2Of |
with,compared |
| R777 |
T774 |
T771 |
arg2Of |
glycoproteins,with |
| R778 |
T774 |
T772 |
arg1Of |
glycoproteins,other |
| R779 |
T774 |
T773 |
arg1Of |
glycoproteins,viral |
| R780 |
T777 |
T776 |
arg1Of |
undertook,therefore |
| R781 |
T775 |
T777 |
arg1Of |
We,undertook |
| R782 |
T780 |
T777 |
arg2Of |
analysis,undertook |
| R783 |
T780 |
T778 |
arg1Of |
analysis,a |
| R784 |
T780 |
T779 |
arg1Of |
analysis,comparative |
| R785 |
T780 |
T781 |
arg1Of |
analysis,of |
| R786 |
T801 |
T781 |
arg2Of |
and,of |
| R787 |
T784 |
T782 |
arg1Of |
shields,viral |
| R788 |
T784 |
T783 |
arg1Of |
shields,glycan |
| R789 |
T784 |
T785 |
arg1Of |
shields,from |
| R790 |
T790 |
T785 |
arg2Of |
proteins,from |
| R791 |
T790 |
T786 |
arg2Of |
proteins,characterized |
| R792 |
T790 |
T787 |
arg1Of |
proteins,class |
| R793 |
T790 |
T788 |
arg1Of |
proteins,I |
| R794 |
T790 |
T789 |
arg1Of |
proteins,fusion |
| R795 |
T792 |
T791 |
arg1Of |
highlight,to |
| R796 |
T784 |
T791 |
modOf |
shields,to |
| R797 |
T793 |
T792 |
arg2Of |
how,highlight |
| R798 |
T796 |
T793 |
arg1Of |
influences,how |
| R799 |
T795 |
T794 |
arg1Of |
density,glycosylation |
| R800 |
T795 |
T796 |
arg1Of |
density,influences |
| R801 |
T799 |
T796 |
arg2Of |
abundance,influences |
| R802 |
T799 |
T797 |
arg1Of |
abundance,oligomannose-type |
| R803 |
T799 |
T798 |
arg1Of |
abundance,glycan |
| R804 |
T801 |
T800 |
arg1Of |
and,"," |
| R805 |
T784 |
T801 |
arg1Of |
shields,and |
| R806 |
T803 |
T801 |
arg2Of |
relationship,and |
| R807 |
T803 |
T802 |
arg1Of |
relationship,the |
| R808 |
T803 |
T804 |
arg1Of |
relationship,between |
| R809 |
T808 |
T804 |
arg2Of |
and,between |
| R810 |
T807 |
T805 |
arg1Of |
shields,effective |
| R811 |
T807 |
T806 |
arg1Of |
shields,glycan |
| R812 |
T807 |
T808 |
arg1Of |
shields,and |
| R813 |
T811 |
T808 |
arg2Of |
ability,and |
| R814 |
T811 |
T809 |
arg1Of |
ability,viral |
| R815 |
T811 |
T810 |
arg1Of |
ability,evasion |
| R816 |
T816 |
T812 |
arg1Of |
underscore,Together |
| R817 |
T816 |
T813 |
arg1Of |
underscore,"," |
| R818 |
T815 |
T814 |
arg1Of |
data,these |
| R819 |
T815 |
T816 |
arg1Of |
data,underscore |
| R820 |
T818 |
T816 |
arg2Of |
importance,underscore |
| R821 |
T818 |
T817 |
arg1Of |
importance,the |
| R822 |
T818 |
T819 |
arg1Of |
importance,of |
| R823 |
T820 |
T819 |
arg2Of |
glycosylation,of |
| R824 |
T818 |
T821 |
arg1Of |
importance,in |
| R825 |
T824 |
T821 |
arg2Of |
evasion,in |
| R826 |
T824 |
T822 |
arg1Of |
evasion,viral |
| R827 |
T824 |
T823 |
arg1Of |
evasion,immune |
